Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A Phase IIb, Randomized, Multicenter, Noncomparative Pilot Study of the Safety and Efficacy of Three
Docetaxel-Based Chemotherapy Regimens plus Bevacizumab ± Trastuzumab for the Adjuvant Treatment of
Patients with Node Positive and High-Risk Node-Negative Breast Cancer (DOCET_L_00714)
Docetaxel
DOCET_L_00714
NCT00365365
Breast Cancer
Phase 2
 
Datasets and document are available as per Sanofi Policy and criteria
July 2017

Powered by ideaPoint, Inc.